AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
1-Year Est. Return 18.84%
This Quarter Est. Return
1 Year Est. Return
+18.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
-$1.28M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
245
New
Increased
Reduced
Closed

Top Buys

1
+$2.73M
2
+$2.36M
3
+$2.06M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.79M
5
APLS icon
Apellis Pharmaceuticals
APLS
+$1.37M

Top Sells

1
+$4.17M
2
+$3.36M
3
+$3.04M
4
UTHR icon
United Therapeutics
UTHR
+$2.96M
5
ONC
BeOne Medicines Ltd
ONC
+$2.13M

Sector Composition

1 Healthcare 57.92%
2 Real Estate 14.45%
3 Financials 7.05%
4 Industrials 3.2%
5 Technology 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACT icon
26
Enact Holdings
ACT
$5.63B
$1.54M 1.14%
42,367
ELS icon
27
Equity Lifestyle Properties
ELS
$12.3B
$1.47M 1.09%
20,611
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.46M 1.09%
20,000
AMPH icon
29
Amphastar Pharmaceuticals
AMPH
$1.2B
$1.46M 1.08%
30,000
+5,000
VRNA
30
DELISTED
Verona Pharma
VRNA
$1.44M 1.07%
50,000
-6,000
GSK icon
31
GSK
GSK
$97.3B
$1.43M 1.06%
35,000
APLS icon
32
Apellis Pharmaceuticals
APLS
$2.52B
$1.37M 1.02%
+47,500
ADAM
33
Adamas Trust
ADAM
$788M
$1.27M 0.95%
200,963
RVNC
34
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.27M 0.95%
245,000
ONC
35
BeOne Medicines Ltd
ONC
$37.4B
$1.23M 0.92%
5,500
-9,500
STXS icon
36
Stereotaxis
STXS
$250M
$1.22M 0.91%
600,000
ENOV icon
37
Enovis
ENOV
$1.37B
$1.18M 0.88%
27,500
+7,500
ROIV icon
38
Roivant Sciences
ROIV
$16.1B
$1.15M 0.86%
100,000
+12,000
GPCR icon
39
Structure Therapeutics
GPCR
$6.26B
$1.14M 0.85%
26,000
TAK icon
40
Takeda Pharmaceutical
TAK
$51.1B
$1.14M 0.85%
+80,000
PTGX icon
41
Protagonist Therapeutics
PTGX
$5.13B
$1.13M 0.84%
25,000
CATX icon
42
Perspective Therapeutics
CATX
$173M
$1.07M 0.79%
80,000
-2,000
CLDX icon
43
Celldex Therapeutics
CLDX
$1.7B
$1.02M 0.76%
30,000
-17,500
PFE icon
44
Pfizer
PFE
$146B
$1.01M 0.75%
35,000
-105,000
SNY icon
45
Sanofi
SNY
$113B
$1.01M 0.75%
17,500
IMVT icon
46
Immunovant
IMVT
$5.29B
$998K 0.74%
35,000
-1,500
LNTH icon
47
Lantheus
LNTH
$4.26B
$988K 0.73%
+9,000
AXSM icon
48
Axsome Therapeutics
AXSM
$8.94B
$944K 0.7%
10,500
-4,500
KPTI icon
49
Karyopharm Therapeutics
KPTI
$116M
$934K 0.69%
75,000
AGNC icon
50
AGNC Investment
AGNC
$12.8B
$885K 0.66%
84,646
1
2
3 4 5